Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Retraction notice to "Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results" [Antiviral Research 142 (2017) 185-192].

Petrova NV, Emelyanova AG, Gorbunov EA, Edwards MR, Walton RP, Bartlett NW, Aniscenko J, Gogsadze L, Bakhsoliani E, Khaitov MR, Johnston SL, Tarasov SA, Epstein OI.

Antiviral Res. 2019 Apr;164:176. doi: 10.1016/j.antiviral.2019.02.010. No abstract available.

PMID:
30885298
2.

Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations.

Singanayagam A, Glanville N, Girkin JL, Ching YM, Marcellini A, Porter JD, Toussaint M, Walton RP, Finney LJ, Aniscenko J, Zhu J, Trujillo-Torralbo MB, Calderazzo MA, Grainge C, Loo SL, Veerati PC, Pathinayake PS, Nichol KS, Reid AT, James PL, Solari R, Wark PAB, Knight DA, Moffatt MF, Cookson WO, Edwards MR, Mallia P, Bartlett NW, Johnston SL.

Nat Commun. 2018 Jun 8;9(1):2229. doi: 10.1038/s41467-018-04574-1.

3.

Cytokine Responses to Rhinovirus and Development of Asthma, Allergic Sensitization, and Respiratory Infections during Childhood.

Custovic A, Belgrave D, Lin L, Bakhsoliani E, Telcian AG, Solari R, Murray CS, Walton RP, Curtin J, Edwards MR, Simpson A, Rattray M, Johnston SL.

Am J Respir Crit Care Med. 2018 May 15;197(10):1265-1274. doi: 10.1164/rccm.201708-1762OC.

4.

Plasmacytoid dendritic cells drive acute asthma exacerbations.

Chairakaki AD, Saridaki MI, Pyrillou K, Mouratis MA, Koltsida O, Walton RP, Bartlett NW, Stavropoulos A, Boon L, Rovina N, Papadopoulos NG, Johnston SL, Andreakos E.

J Allergy Clin Immunol. 2018 Aug;142(2):542-556.e12. doi: 10.1016/j.jaci.2017.08.032. Epub 2017 Oct 17.

5.

Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness.

Edwards MR, Strong K, Cameron A, Walton RP, Jackson DJ, Johnston SL.

J Allergy Clin Immunol. 2017 Oct;140(4):909-920. doi: 10.1016/j.jaci.2017.07.025. Review.

6.

The potential of anti-infectives and immunomodulators as therapies for asthma and asthma exacerbations.

Edwards MR, Walton RP, Jackson DJ, Feleszko W, Skevaki C, Jartti T, Makrinoti H, Nikonova A, Shilovskiy IP, Schwarze J, Johnston SL, Khaitov MR; EAACI Anti-infectives in Asthma and Asthma Exacerbations Task Force.

Allergy. 2018 Jan;73(1):50-63. doi: 10.1111/all.13257. Epub 2017 Aug 10. Review.

7.

Update on Biomarkers to Monitor Clinical Efficacy Response During and Post Treatment in Allergen Immunotherapy.

Kouser L, Kappen J, Walton RP, Shamji MH.

Curr Treat Options Allergy. 2017;4(1):43-53. doi: 10.1007/s40521-017-0117-5. Epub 2017 Mar 10. Review.

8.

Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results.

Petrova NV, Emelyanova AG, Gorbunov EA, Edwards MR, Walton RP, Bartlett NW, Aniscenko J, Gogsadze L, Bakhsoliani E, Khaitov MR, Johnston SL, Tarasov SA, Epstein OI.

Antiviral Res. 2017 Jun;142:185-192. doi: 10.1016/j.antiviral.2017.03.017. Epub 2017 Mar 27. Retraction in: Antiviral Res. 2019 Apr;164:176.

9.

Mucosal Type 2 Innate Lymphoid Cells Are a Key Component of the Allergic Response to Aeroallergens.

Dhariwal J, Cameron A, Trujillo-Torralbo MB, Del Rosario A, Bakhsoliani E, Paulsen M, Jackson DJ, Edwards MR, Rana BMJ, Cousins DJ, Hansel TT, Johnston SL, Walton RP; MRC-GSK Strategic Alliance Consortium.

Am J Respir Crit Care Med. 2017 Jun 15;195(12):1586-1596. doi: 10.1164/rccm.201609-1846OC.

10.

Tbet Deficiency Causes T Helper Cell Dependent Airways Eosinophilia and Mucus Hypersecretion in Response to Rhinovirus Infection.

Glanville N, Peel TJ, Schröder A, Aniscenko J, Walton RP, Finotto S, Johnston SL.

PLoS Pathog. 2016 Sep 28;12(9):e1005913. doi: 10.1371/journal.ppat.1005913. eCollection 2016 Sep.

11.

Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium.

Porter JD, Watson J, Roberts LR, Gill SK, Groves H, Dhariwal J, Almond MH, Wong E, Walton RP, Jones LH, Tregoning J, Kilty I, Johnston SL, Edwards MR.

J Antimicrob Chemother. 2016 Oct;71(10):2767-81. doi: 10.1093/jac/dkw222. Epub 2016 Jul 25.

12.

Nasal Lipopolysaccharide Challenge and Cytokine Measurement Reflects Innate Mucosal Immune Responsiveness.

Dhariwal J, Kitson J, Jones RE, Nicholson G, Tunstall T, Walton RP, Francombe G, Gilbert J, Tan AJ, Murdoch R, Kon OM, Openshaw PJ, Hansel TT.

PLoS One. 2015 Sep 14;10(9):e0135363. doi: 10.1371/journal.pone.0135363. eCollection 2015.

13.

A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD.

Singanayagam A, Glanville N, Walton RP, Aniscenko J, Pearson RM, Pinkerton JW, Horvat JC, Hansbro PM, Bartlett NW, Johnston SL.

Clin Sci (Lond). 2015 Aug;129(3):245-58. doi: 10.1042/CS20140654.

14.

The influence of asthma control on the severity of virus-induced asthma exacerbations.

Jackson DJ, Trujillo-Torralbo MB, del-Rosario J, Bartlett NW, Edwards MR, Mallia P, Walton RP, Johnston SL.

J Allergy Clin Immunol. 2015 Aug;136(2):497-500.e3. doi: 10.1016/j.jaci.2015.01.028. Epub 2015 Mar 13. No abstract available.

15.

Interleukin-18 is associated with protection against rhinovirus-induced colds and asthma exacerbations.

Jackson DJ, Glanville N, Trujillo-Torralbo MB, Shamji BW, Del-Rosario J, Mallia P, Edwards MJ, Walton RP, Edwards MR, Johnston SL.

Clin Infect Dis. 2015 May 15;60(10):1528-31. doi: 10.1093/cid/civ062. Epub 2015 Feb 2.

16.

IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.

Jackson DJ, Makrinioti H, Rana BM, Shamji BW, Trujillo-Torralbo MB, Footitt J, Jerico Del-Rosario, Telcian AG, Nikonova A, Zhu J, Aniscenko J, Gogsadze L, Bakhsoliani E, Traub S, Dhariwal J, Porter J, Hunt D, Hunt T, Hunt T, Stanciu LA, Khaitov M, Bartlett NW, Edwards MR, Kon OM, Mallia P, Papadopoulos NG, Akdis CA, Westwick J, Edwards MJ, Cousins DJ, Walton RP, Johnston SL.

Am J Respir Crit Care Med. 2014 Dec 15;190(12):1373-82. doi: 10.1164/rccm.201406-1039OC.

17.

Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation.

Beale J, Jayaraman A, Jackson DJ, Macintyre JDR, Edwards MR, Walton RP, Zhu J, Man Ching Y, Shamji B, Edwards M, Westwick J, Cousins DJ, Yi Hwang Y, McKenzie A, Johnston SL, Bartlett NW.

Sci Transl Med. 2014 Oct 1;6(256):256ra134. doi: 10.1126/scitranslmed.3009124.

18.

Role of interleukin 33 in respiratory allergy and asthma.

Makrinioti H, Toussaint M, Jackson DJ, Walton RP, Johnston SL.

Lancet Respir Med. 2014 Mar;2(3):226-37. doi: 10.1016/S2213-2600(13)70261-3. Epub 2014 Jan 23. Review.

PMID:
24621684
19.

Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein.

Glanville N, McLean GR, Guy B, Lecouturier V, Berry C, Girerd Y, Gregoire C, Walton RP, Pearson RM, Kebadze T, Burdin N, Bartlett NW, Almond JW, Johnston SL.

PLoS Pathog. 2013;9(9):e1003669. doi: 10.1371/journal.ppat.1003669. Epub 2013 Sep 26.

20.

An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation.

Traub S, Nikonova A, Carruthers A, Dunmore R, Vousden KA, Gogsadze L, Hao W, Zhu Q, Bernard K, Zhu J, Dymond M, McLean GR, Walton RP, Glanville N, Humbles A, Khaitov M, Wells T, Kolbeck R, Leishman AJ, Sleeman MA, Bartlett NW, Johnston SL.

PLoS Pathog. 2013;9(8):e1003520. doi: 10.1371/journal.ppat.1003520. Epub 2013 Aug 1.

21.

γδT cells suppress inflammation and disease during rhinovirus-induced asthma exacerbations.

Glanville N, Message SD, Walton RP, Pearson RM, Parker HL, Laza-Stanca V, Mallia P, Kebadze T, Contoli M, Kon OM, Papi A, Stanciu LA, Johnston SL, Bartlett NW.

Mucosal Immunol. 2013 Nov;6(6):1091-100. doi: 10.1038/mi.2013.3. Epub 2013 Feb 6.

22.

Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1.

McLean GR, Walton RP, Shetty S, Peel TJ, Paktiawal N, Kebadze T, Gogsadze L, Niespodziana K, Valenta R, Bartlett NW, Johnston SL.

Antiviral Res. 2012 Sep;95(3):193-201. doi: 10.1016/j.antiviral.2012.06.006. Epub 2012 Jun 26. Erratum in: Antiviral Res. 2013 Mar;97(3):381. Peel, Tamlyn J [added].

PMID:
22742898
23.

Rhinovirus infection induces expression of airway remodelling factors in vitro and in vivo.

Kuo C, Lim S, King NJ, Bartlett NW, Walton RP, Zhu J, Glanville N, Aniscenko J, Johnston SL, Burgess JK, Black JL, Oliver BG.

Respirology. 2011 Feb;16(2):367-77. doi: 10.1111/j.1440-1843.2010.01918.x. Erratum in: Respirology. 2012 Jan;17(1):192.

PMID:
21199160
24.

Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium.

Slater L, Bartlett NW, Haas JJ, Zhu J, Message SD, Walton RP, Sykes A, Dahdaleh S, Clarke DL, Belvisi MG, Kon OM, Fujita T, Jeffery PK, Johnston SL, Edwards MR.

PLoS Pathog. 2010 Nov 4;6(11):e1001178. doi: 10.1371/journal.ppat.1001178. Erratum in: PLoS Pathog. 2012 Apr;8(4): doi/10.1371/annotation/c3f58c59-a42f-495b-a4f2-d74d55d72166.

25.

Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells.

Khaitov MR, Laza-Stanca V, Edwards MR, Walton RP, Rohde G, Contoli M, Papi A, Stanciu LA, Kotenko SV, Johnston SL.

Allergy. 2009 Mar;64(3):375-86. doi: 10.1111/j.1398-9995.2008.01826.x. Epub 2009 Jan 28.

PMID:
19175599
26.

Role of respiratory viral infections in the development of atopic conditions.

Walton RP, Johnston SL.

Curr Opin Allergy Clin Immunol. 2008 Apr;8(2):150-3. doi: 10.1097/ACI.0b013e3282f889df. Review.

PMID:
18317024
27.

Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation.

Bartlett NW, Walton RP, Edwards MR, Aniscenko J, Caramori G, Zhu J, Glanville N, Choy KJ, Jourdan P, Burnet J, Tuthill TJ, Pedrick MS, Hurle MJ, Plumpton C, Sharp NA, Bussell JN, Swallow DM, Schwarze J, Guy B, Almond JW, Jeffery PK, Lloyd CM, Papi A, Killington RA, Rowlands DJ, Blair ED, Clarke NJ, Johnston SL.

Nat Med. 2008 Feb;14(2):199-204. doi: 10.1038/nm1713. Epub 2008 Feb 3.

28.

'Amb-Track.' Development of a surgicenter model within a main operating room.

Covell CA, Walton RP.

AORN J. 1994 Jun;59(6):1257-65. No abstract available.

PMID:
8048804
29.

Best of both worlds: part-time nurse managers.

Walton RP.

Nurs Manage. 1993 Mar;24(3):64I, 64L, 64P.

PMID:
8455899
30.

[Intravascular persistence, tissue storage and excretion of hydroxyethyl starch (HAS)].

Thompson WL, Fukushima T, Rutherford RB, Walton RP.

Infusionsther Klin Ernahr. 1979 Jun;6(3):151-5. German.

PMID:
88413
31.

Catecholamines and local rebound in left ventricular contractile force after release of coronary artery occlusion.

Newman WH, Mathur PP, Walton RP.

Cardiovasc Res. 1971 Jan;5(1):81-5. No abstract available.

PMID:
4395932
32.

Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch.

Thompson WL, Fukushima T, Rutherford RB, Walton RP.

Surg Gynecol Obstet. 1970 Nov;131(5):965-72. No abstract available.

PMID:
5471548
33.

Abrupt coronary arterial occlusion and the distribution of tension in the canine left ventricle.

Newman WH, Walton RP.

Arch Int Pharmacodyn Ther. 1969 Jun;179(2):442-51. No abstract available.

PMID:
5367314
34.

Alterations in left ventricular dimensions and mural force following coronary occlusion.

Newman WH, Walton RP.

Am J Physiol. 1968 Jun;214(6):1388-91. No abstract available.

PMID:
5649496
35.

Strain-gauge arch recordings from an acutely ischemic area of the left ventricle.

Newman WH, Walton RP.

J Appl Physiol. 1967 Sep;23(3):398-400. No abstract available.

PMID:
6047962
36.

Limitation of myocardial function by reduced coronary blood flow during isoproterenol action.

Daniell HB, Bagwell EE, Walton RP.

Circ Res. 1967 Jul;21(1):85-98. No abstract available.

PMID:
6028858
37.

Correlation of cardiac plethysmography with other circulatory recordings during the action of anesthetics and cardiac stimulants.

Bernhoff SA, Bagwell EE, Walton RP.

Acta Anaesthesiol Scand. 1967;11(3):221-9. No abstract available.

PMID:
6060404
38.

Structural specificity of dextran in producing anaphylactoid reactions in rats.

Walton RP, Hauck AL, Herman EH.

Proc Soc Exp Biol Med. 1966 Jan;121(1):272-4. No abstract available.

PMID:
5902944
39.

A medical school's function--"teaching" or "research"?

Walton RP.

J S C Med Assoc. 1965 Sep;61(9):290. No abstract available.

PMID:
5212729
40.

CIRCULATORY RESPONSES TO INTRAVENOUS INFUSIONS OF HYDROXYETHYL STARCH SOLUTIONS.

THOMPSON WL, WALTON RP.

J Pharmacol Exp Ther. 1964 Dec;146:359-64. No abstract available.

PMID:
14254330
41.

BLEEDING VOLUME INDICES OF HYDROXYETHYL STARCH, DEXTRAN, BLOOD, AND GLUCOSE.

THOMPSON WL, WAYT DH, WALTON RP.

Proc Soc Exp Biol Med. 1964 Feb;115:474-7. No abstract available.

PMID:
14121642
42.

RECENT ADVANCES IN THE USE OF DRUGS IN CARDIAC SURGERY.

WALTON RP.

Listing Res Cardiovasc Field. 1964;10:138-9. No abstract available.

PMID:
24547398
43.

ELEVATION OF PLASMA HISTAMINE LEVELS IN THE DOG FOLLOWING ADMINISTRATION OF MUSCLE RELAXANTS, OPIATES AND MACROMOLECULAR POLYMERS.

THOMPSON WL, WALTON RP.

J Pharmacol Exp Ther. 1964 Jan;143:131-6. No abstract available.

PMID:
14118078
44.

Basic identity of certain drug responses of the canine and human myocardium.

WALTON RP.

Arch Int Pharmacodyn Ther. 1962 Dec 1;140:615-22. No abstract available.

PMID:
13998747
45.

Persistence of starch derivatives and dextran when infused after hemorrhage.

THOMPSON WL, BRITTON JJ, WALTON RP.

J Pharmacol Exp Ther. 1962 Apr;136:125-32. No abstract available.

PMID:
13920952
46.

Spinal cord site of action of resorcinol isomers that produce sympathetic circulatory stimulation.

GATGOUNIS J, WALTON RP.

J Pharmacol Exp Ther. 1962 Feb;135:174-9. No abstract available.

PMID:
13897243
47.

Resorcinol isomers and pentylenetetrazol; their centrally mediated sympathetic circulatory effects.

GATGOUNIS J, WALTON RP.

J Pharmacol Exp Ther. 1960 Apr;128:363-71. No abstract available.

PMID:
13826845
48.

Hypotension and histamine release following intravenous injection of plasma substitutes.

WALTON RP, RICHARDSON JA, THOMPSON WL.

J Pharmacol Exp Ther. 1959 Sep;127:39-45. No abstract available.

PMID:
13842765
49.

Sympathetic influences during hemorrhagic hypotension.

WALTON RP, RICHARDSON JA, WALTON RP Jr, THOMPSON WL.

Am J Physiol. 1959 Jul;197(1):223-30. No abstract available.

PMID:
13661429
50.

Effects of drugs on ballistocardiographic recordings; correlation with other cardiovascular measurements in the dog and in man.

DARBY TD, WALTON RP, GAZES PC.

Am J Cardiol. 1959 May;3(5):668-75. No abstract available.

PMID:
13649593

Supplemental Content

Loading ...
Support Center